CalciMedica (CALC) Change in Acquisitions & Divestments (2020 - 2026)
CalciMedica's (CALC) quarterly Change in Acquisitions & Divestments came in at $1.5 million in Q1 2026, down 72.22% YoY from $5.4 million in Q1 2025, and down 80.39% on a QoQ basis from $7.6 million in Q4 2025.
CalciMedica (CALC) Change in Acquisitions & Divestments (2020 - 2026) Analysis & Trends
CalciMedica (CALC) has 7 years of Change in Acquisitions & Divestments data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 72.22% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.6 million (down 14.43% YoY) and the FY2025 annual result came in at $25.5 million, up 3.69% from the prior year.
- Change in Acquisitions & Divestments slipped to $1.5 million in Q1 2026, from $7.6 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $17.8 million in Q4 2022 to a low of $500000.0 in Q4 2023.
- A 5-year average of $8.2 million and a median of $6.4 million in 2025 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments slumped 97.18% — and 2024, when it surged 900.0%.
- Tracing CALC's Change in Acquisitions & Divestments over 5 years: stood at $17.8 million in 2022, then tumbled by 97.18% to $500000.0 in 2023, then surged by 900.0% to $5.0 million in 2024, then jumped by 53.0% to $7.6 million in 2025, then sank by 80.39% to $1.5 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $1.5 million (Q1 2026), $7.6 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.50 Mn |
| Mar 31, 2026 | 1.50 Mn |
| Dec 31, 2025 | 7.65 Mn |
| Dec 31, 2025 | 7.65 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Sep 30, 2025 | 5.00 Mn |
| Jun 30, 2025 | 7.45 Mn |
| Jun 30, 2025 | 7.45 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Mar 31, 2025 | 5.40 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Dec 31, 2024 | 5.00 Mn |
| Sep 30, 2024 | 9.74 Mn |
| Sep 30, 2024 | 9.74 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Jun 30, 2024 | 5.10 Mn |
| Mar 31, 2024 | 4.75 Mn |
| Mar 31, 2024 | 4.75 Mn |
| Dec 31, 2023 | 500,000.00 |
| Dec 31, 2023 | 500,000.00 |